The Prognostic Value of COX-2 in Predicting Metastasis of Patients with Colorectal Cancer: A Systematic Review and Meta Analysis

Overview

Journal Heliyon

Specialty Social Sciences

Date 2023 Oct 25

PMID 37876424

Authors

Andriana Purnama

Kiki Lukman

Reno Rudiman

Dwi Prasetyo

Yoni Fuadah

Prapanca Nugraha

Valeska Siulinda Candrawinata

Affiliations

Soon will be listed here.

Abstract

Introduction: COX-2 is overexpressed in colorectal tumour tissue relative to the healthy colonic mucosa, thus we investigated the prognostic significance of COX-2 in determining the metastasis of patients with colorectal cancer.

Methods: PubMed, EMBASE, and Cochrane Library were searched using the following terms colorectal cancer, colon cancer, rectal cancer, colorectal carcinoma, Cyclooxygenase-2, and prognosis to identify articles providing information on the prognostic importance of COX-2 in adult patients with metastatic colorectal cancer. Review papers, non-research letters, comments, case reports, animal studies, original research with sample sizes of fewer than 20, case reports and series, non-English language articles, and pediatric studies (those under the age of 17) were excluded. The Newcastle Ottawa Scale (NOS) was used to assess the credibility of the included studies. The full texts were evaluated and this study complied with the terms of the local protocol and the Helsinki Declaration.

Results: Eight relevant studies were included in this review involving 937 patients. The meta-analysis revealed that COX-2 expression is associated with lymph node invasion (RR 1.85 [1.21, 2.83], P = 0.005, I2 = 88 %) and liver metastasis (RR 4.90 [1.12, 21.57], P = 0.04, I2 = 42 %), but not with venous dissemination (RR 1.48 [0.72, 3.03], P = 0.28, I2 = 87 %).

Conclusion: COX-2 expression is associated with lymph node invasion in colorectal cancer but further studies are required to determine the prognostic significance of COX-2 expression in determining metastasis status for colorectal cancer patients.

Citing Articles

Laparoscopic surgery is associated with increased risk of postoperative peritoneal metastases in T4 colon cancer: a propensity score analysis.

Li S, Ye-Wang , Cheng-Xin , Ji L, Li S, Jiang W Int J Colorectal Dis. 2025; 40(1):2.

PMID: 39743636 PMC: 11693618. DOI: 10.1007/s00384-024-04773-x.

NF-κB pathway and angiogenesis: insights into colorectal cancer development and therapeutic targets.

Bahrami A, Khalaji A, Najafi M, Sadati S, Raisi A, Abolhassani A Eur J Med Res. 2024; 29(1):610.

PMID: 39702532 PMC: 11658081. DOI: 10.1186/s40001-024-02168-w.

The prognostic value of COX-2 in predicting metastasis of patients with colorectal cancer: A systematic review and meta analysis.

Purnama A, Lukman K, Rudiman R, Prasetyo D, Fuadah Y, Nugraha P Heliyon. 2023; 9(10):e21051.

PMID: 37876424 PMC: 10590949. DOI: 10.1016/j.heliyon.2023.e21051.

References

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

Gallo O, Masini E, Bianchi B, Bruschini L, Paglierani M, Franchi A . Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma. Hum Pathol. 2002; 33(7):708-14. DOI: 10.1053/hupa.2002.125376. View

Mann J, DuBois R . Cyclooxygenase-2 and gastrointestinal cancer. Cancer J. 2004; 10(3):145-52. DOI: 10.1097/00130404-200405000-00001. View

Sicking I, Rommens K, Battista M, Bohm D, Gebhard S, Lebrecht A . Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients. BMC Cancer. 2014; 14:952. PMC: 4302078. DOI: 10.1186/1471-2407-14-952. View

Naruse T, Nishida Y, Hosono K, Ishiguro N . Meloxicam inhibits osteosarcoma growth, invasiveness and metastasis by COX-2-dependent and independent routes. Carcinogenesis. 2005; 27(3):584-92. DOI: 10.1093/carcin/bgi240. View

Urakawa H, Nishida Y, Naruse T, Nakashima H, Ishiguro N . Cyclooxygenase-2 overexpression predicts poor survival in patients with high-grade extremity osteosarcoma: a pilot study. Clin Orthop Relat Res. 2009; 467(11):2932-8. PMC: 2758970. DOI: 10.1007/s11999-009-0814-x. View

Pancione M, Forte N, Sabatino L, Tomaselli E, Parente D, Febbraro A . Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome. Hum Pathol. 2009; 40(5):714-25. DOI: 10.1016/j.humpath.2008.08.019. View

Murata H, Kawano S, Tsuji S, Tsuji M, Sawaoka H, Kimura Y . Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am J Gastroenterol. 1999; 94(2):451-5. DOI: 10.1111/j.1572-0241.1999.876_e.x. View

Gupta R, DuBois R . Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer. 2002; 1(1):11-21. DOI: 10.1038/35094017. View

10.

Rao M, Yang W, Seifalian A, Winslet M . Role of cyclooxygenase-2 in the angiogenesis of colorectal cancer. Int J Colorectal Dis. 2003; 19(1):1-11. DOI: 10.1007/s00384-003-0511-2. View

11.

Tsujii M, DuBois R . Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell. 1995; 83(3):493-501. DOI: 10.1016/0092-8674(95)90127-2. View

12.

Purnama A, Lukman K, Rudiman R, Prasetyo D, Fuadah Y, Nugraha P . The prognostic value of COX-2 in predicting metastasis of patients with colorectal cancer: A systematic review and meta analysis. Heliyon. 2023; 9(10):e21051. PMC: 10590949. DOI: 10.1016/j.heliyon.2023.e21051. View

13.

Vetsika E, Koukos A, Kotsakis A . Myeloid-Derived Suppressor Cells: Major Figures that Shape the Immunosuppressive and Angiogenic Network in Cancer. Cells. 2019; 8(12). PMC: 6953061. DOI: 10.3390/cells8121647. View

14.

Raza A, Khan A, Inchakalody V, Mestiri S, Yoosuf Z, Bedhiafi T . Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer. J Exp Clin Cancer Res. 2022; 41(1):99. PMC: 8922757. DOI: 10.1186/s13046-022-02318-0. View

15.

Ristimaki A, Sivula A, Lundin J, Lundin M, Salminen T, Haglund C . Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res. 2002; 62(3):632-5. View

16.

Peng J, Su C, Chang H, Chai C, Hung W . Overexpression of cyclo-oxygenase 2 in squamous cell carcinoma of the hypopharynx. Hum Pathol. 2002; 33(1):100-4. DOI: 10.1053/hupa.2002.30187. View

17.

Benedicto A, Romayor I, Arteta B . CXCR4 receptor blockage reduces the contribution of tumor and stromal cells to the metastatic growth in the liver. Oncol Rep. 2018; 39(4):2022-2030. DOI: 10.3892/or.2018.6254. View

18.

Ye Y, Xu Y, Lai Y, He W, Li Y, Wang R . Long non-coding RNA cox-2 prevents immune evasion and metastasis of hepatocellular carcinoma by altering M1/M2 macrophage polarization. J Cell Biochem. 2017; 119(3):2951-2963. DOI: 10.1002/jcb.26509. View

19.

Wang R, Dai W, Gong J, Huang M, Hu T, Li H . Development of a novel combined nomogram model integrating deep learning-pathomics, radiomics and immunoscore to predict postoperative outcome of colorectal cancer lung metastasis patients. J Hematol Oncol. 2022; 15(1):11. PMC: 8785554. DOI: 10.1186/s13045-022-01225-3. View

20.

Konno H, Baba M, Shoji T, Ohta M, Suzuki S, Nakamura S . Cyclooxygenase-2 expression correlates with uPAR levels and is responsible for poor prognosis of colorectal cancer. Clin Exp Metastasis. 2002; 19(6):527-34. DOI: 10.1023/a:1020392309715. View